Last updated 16 days ago

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

1530 patients around the world
Available in Spain, United States, Chile, Argentina
Regeneron Pharmaceuticals
7Research sites
1530Patients around the world
This study is for people with
Skin cancer
Melanoma
Requirements for the patient
From 12 Years
All Gender
Medical requirements
Sites
DIABAID – Instituto de asistencia integral en diabetes y patologías crónicas, CABA, Buenos Aires
Recruiting
Paraguay 1570, CABA, Buenos Aires
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
25 de mayo 174, Viedma, Río Negro
Centro de Investigación Pergamino SA
Recruiting
Av. de Mayo 1115, Pergamino, Buenos Aires
Instituto de Oncología de Rosario - IOR
Recruiting
Córdoba 2457, Rosario, Santa Fe
Centro Médico San Roque S.R.L. - Tucumán
Recruiting
Balcarce 579, Tucumán
Fundación CENIT para la Investigación en Neurociencias
Recruiting
Juncal 2222, C1125 CABA, Argentina
Oncocentro APYS - Valparaíso
Recruiting
Avenida La Marina 1702, Viña del Mar, Valparaíso
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy